Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
American Air Liquide Holdings history
American Air Liquide Holdings company history timeline
On November 8, 1902, a public limited company was incorporated with capital of 100,000 French francs subscribed by 24 shareholders.
In 1903 Delorme issued 725 new shares and offered 100 of these shares for sale.
By the third quarter of 1906, L'Air Liquide had overcome its financial problems, and during that year the company earned its first dividends.
1906: Air Liquide opens plants in Brazil and Belgium.
1908: Company begins production of oxygen.
As early as 1916 L'Air Liquide entered into a joint venture with Rockefeller and Hollingsworth to form L'Air Reduction Company in the United States.
He was released from prison in 1950.
1969: Air Liquide opens United States subsidiary.
In 1985 the company entered into a joint venture with Whemo Denko of Japan to supply NASDA, the Japanese Space Agency, with liquid hydrogen.
In 1993, the company reorganized its operations into a decentralized, regionally focused structure in an effort to bring the company closer to its customers.
1994: Air Liquide begins power cogeneration activities, including acquisition of power generation company Bayou Cogen and construction of new plants in Italy, the Netherlands, and France.
Despite BOC's agreement to be acquired, the deal, worth $11.4 billion, was rejected by the FTC in the United States; in 2000, BOC, Air Liquide, and Air Products called off the proposed acquisition.
2001: Air Liquide rejects takeover offer by Suez Lyonnaise des Eaux, acquires full control of Hede Nielsen A/S in Denmark.
As it prepared to celebrate its 100th anniversary in 2002, Air Liquide continued to build up its global position through smaller-scale acquisitions.
The Delaware Research & Technology Center (DRTC), one of Air Liquide’s nine major R&D centers worldwide, was established in Newark, Delaware in 2007.
Conscious of the strategic dimension of Engineering & Construction capabilities, the Group acquired Lurgi in 2007.
At the end of 2012, two major home healthcare players joined the Group: LVL Médical in France and Gasmedi in Spain.
Air Liquide has endeavored to forge a strong and privileged relationship with its shareholders based on exceptional stock market performance, with an average annual increase in its share price over the 100 years to 2013 of +11.9%.
In 2013, Air Liquide launched two initiatives to promote open innovation: i-Lab (innovation Lab) and ALIAD, the Group’s capital risk subsidiary, to make minority investments in innovative technology start-ups.
In 2015, Air Liquide inaugurated Cryocap™ in France, a unique industrial installation that enables the capture of CO2 released during hydrogen production via a cryogenic process.
On May 23, 2016, Air Liquide completed the acquisition of the American company Airgas.
At the end of 2017, the world’s largest oxygen production unit was commissioned by the Group in South Africa for its customer Sasol.
Moreover, the Hydrogen Council, which was founded in 2017, brings together more than 50 global leaders in the energy, transport and industry sectors to promote hydrogen with a view to achieving climate change-related objectives, and has held a meeting in China for the first time
The Gas & Services businesses now represent 96% of the Group’s revenue at the end of 2018.
The 300 million US dollar target will be reached at the beginning of 2019, i.e., more than a year before initially planned.
From 2019, the Innovation Campus will also host a deep-tech start-up accelerator
Rate how well American Air Liquide Holdings lives up to its initial vision.
American Air Liquide Holdings jobs
Do you work at American Air Liquide Holdings?
Is American Air Liquide Holdings' vision a big part of strategic planning?
American Air Liquide Holdings competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Regeneron | 1988 | $14.2B | 9,123 | 394 |
| Opexa Therapeutics | 1986 | $2.9M | 23 | - |
| BioMarin | 1997 | $2.9B | 2,581 | 64 |
| Sanofi Genzyme | 1981 | $4.6B | 12,000 | - |
| International Training & Education Center For Health (i-tech) | - | $21.0M | 750 | - |
| McNeil Consumer Healthcare | 1879 | $46.2M | 17 | - |
| Medimmune | 1987 | $422.2M | 6,030 | - |
| Celera | 1998 | - | 750 | - |
| Genentech | 1976 | $166.9M | 13,638 | 775 |
| Luminex | 1995 | $417.4M | 1,140 | 5 |
American Air Liquide Holdings history FAQs
Zippia gives an in-depth look into the details of American Air Liquide Holdings, including salaries, political affiliations, employee data, and more, in order to inform job seekers about American Air Liquide Holdings. The employee data is based on information from people who have self-reported their past or current employments at American Air Liquide Holdings. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by American Air Liquide Holdings. The data presented on this page does not represent the view of American Air Liquide Holdings and its employees or that of Zippia.
American Air Liquide Holdings may also be known as or be related to American Air Liquide Holdings Inc, Air Liquide SA, Air It Is, LLC and American Air Liquide Holdings Inc.